Psilocybin is under clinical development by Filament Health and currently in Phase I for Substance (Drug) Abuse.

Psilocybin is under clinical development by Filament Health and currently in Phase I for Major Depressive Disorder.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Discover why psychiatrists are moving beyond single-treatment approaches and how combining therapies could be the key to ...

Glutamatergic medications showed promise in treating obsessive-compulsive and related disorders (OCRDs), especially obsessive ...

Jesse Eisenberg's "A Real Pain," starring Kieran Culkin, is available to rent/purchase on digital platforms. Here's how to ...

The reasons most people hoard is because they have an extreme sentimental attachment to their possessions, or they believe ...

A groundbreaking depression treatment co-pioneered by Queensland researchers using a new form of brain stimulation will begin ...

Award highlights Relief Mental Health's commitment to exceptional patient care and innovative treatments in Red Bank, NJ ...